The Vanguard Group 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 12:14 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,596,768 4.700% |
-206,197 (-7.36%) |
Filing |
| 2024-11-12 4:01 pm Unchanged |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,802,965 5.080% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,802,965 5.080% |
2,802,965 (New Position) |
Filing |